See Photos from the First Lunar Travelers Since 1972

47% - The White House has proposed cutting NASA's science budget by 47%, and for the first time in 40 years NASA has not committed to starting any new science missions, creating material funding uncertainty for future programs. NASA simultaneously released the first photos from Artemis II, the first crewed lunar mission in over 50 years, with a four-person crew (including Victor Glover and Christina Koch) set to loop the far side of the Moon on Day 6 of a 10-day mission and return without landing.

Analysis

The principal market consequence is a reallocation of optionality away from long-horizon science/R&D programs toward near-term procurement and operational work. That favors firms and business lines that can convert backlog into cash within 6-24 months (defense primes, launch ops, mission integration) and penalizes narrow suppliers whose revenue depends on new-start science missions (instruments, specialty optics, cryo systems). The timing matters: contract re-scopes and award cadence change within the next budget cycle (3-9 months), but revenue realization for affected suppliers will lag 12-36 months because of long program pipelines.

Second-order supply-chain effects will compress venture and university-funded innovation. Reduced government-sponsored science flows reduce follow-on commercial spinouts and tighten the pool of engineering talent for niche subsystems, raising input costs for survivors and increasing strategic value of companies that own repeatable production lines and long-term service contracts. Expect margin dispersion to widen across the sector as firms with recurring sustainment work capture pricing power while single-mission vendors face fixed-cost leverage.

Political and commercial catalysts that could reverse these moves are concrete: appropriations riders, public pressure after high-visibility missions, or private-sector stepping in with commercial contracts; any of these can restore program greenlights within 3-9 months and normalize supplier order books within 12-24 months. Execution risk is the other axis — commercial launch incumbents and smaller public space firms have well-documented delivery/production risks that could flip winners to losers quickly if milestones slip.

Practical investment approach is to play structural winners (commercial launch + defense primes with serviceable backlog) and short or underweight single-mission-dependent suppliers, sizing positions for a multi-quarter policy/data cadence and keeping tight event-driven stops tied to appropriations votes and contract announcements.

Key Decisions for Investors

• Pair trade (6-18 months): Long RKLB (Rocket Lab) 2-3% NAV vs Short MAXR (Maxar) 1-2% NAV. Rationale: RKLB benefits from commercial small-sat and responsive launch demand plus DoD tasking windows; MAXR is more exposed to deferred government science/EO spend. Size asymmetric: larger long, smaller short; stop-loss 20% on RKLB and 15% on MAXR; target 40-60% gross on the pair if appropriations remain constrained.
• Tactical defensive long (12-24 months): Long LMT (Lockheed Martin) 2-4% NAV. Rationale: entrenched systems integrators with steady FCF and close DoD ties will capture reallocated spend. Use a 12% trailing stop; target total return 15-25% with dividend cushion.
• Macro/sector play (3-9 months): Buy XAR or ITA on any >3% intraday dip following budget votes — allocate 1-2% NAV. Rationale: diversified aerospace/defense exposure reduces single-name execution risk while capturing rotation into procurement. Take profits incrementally on signs of congressional restoration of science budgets.
• Event-driven short (3-12 months): Short or underweight pure-play Earth-observation/science vendors (e.g., PL, MAXR) into any rally, backed by options hedges. Rationale: these names face the largest demand contraction if new-start science missions are deferred; tight stops keyed to contract award notices and appropriations amendments to limit policy reversal risk.